IDEAYA Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Hi. I am Anthony Yu, an Executive Director with Morgan Stanley in the investment banking division. Welcome to the IDEAYA fireside chat at the Morgan Stanley Global Healthcare Conference. I'm joined on stage by CEO, Yujiro Hata. Let me just briefly read the research disclosure here. So for important disclosures, please see the Morgan Stanley research disclosure website at w.w.w.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
So with that, before we dive in, I think just some level setting, obviously some exciting data announcements yesterday and this morning. But to take a step back and do a little bit of table setting, I wanted to get a sense for your take on how the precision medicine and synthetic lethality landscape has sort of changed over time. And within that, how IDEAYA is positioned. And maybe another way of putting that, how does -- how are you differentiated
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
